Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1980 Dec;39(6):576–579. doi: 10.1136/ard.39.6.576

Gold in erythrocytes, whole blood, and plasma during long-term chrysotherapy.

S M Pedersen, P M Graabaek
PMCID: PMC1000624  PMID: 7458435

Abstract

The concentrations of gold in erythrocytes, whole blood, cell-rich plasma, and cell-free plasma were investigated in 17 patients with rheumatoid arthritis undergoing long-term chrysotherapy. Gold estimations were performed with a graphite tube atomic absorption spectrophotometer. Significant quantities of gold were found in isolated erythrocytes of 12 patients. There was no correlation between erythrocyte gold and therapeutic response, plasma gold, and gold in whole blood. Nor did gold in whole blood or plasma show any correlation with therapeutic responses and toxic reaction. However, all patients (3) with toxic reactions had a significantly higher gold concentration in the erythrocytes than the patients without toxic reactions. This result indicates that erythrocyte gold estimations could provide a useful warning of impeding toxic reactions.

Full text

PDF
576

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Billings R., Grahame R., Marks V., Wood P. J., Taylor A. Blood and urine gold levels during chrysotherapy for rheumatoid arthritis. Rheumatol Rehabil. 1975 Feb;14(1):13–18. doi: 10.1093/rheumatology/14.1.13. [DOI] [PubMed] [Google Scholar]
  2. Francois P. E., Goldberg I. J., Lawton K., Al-Ani D. T., Redding J. H. Distribution of gold in blood during chrysotherapy. Ann Clin Biochem. 1978 Nov;15(6):324–325. doi: 10.1177/000456327801500177. [DOI] [PubMed] [Google Scholar]
  3. Freyberg R. H., Block W. D., Levey S. METABOLISM, TOXICITY AND MANNER OF ACTION OF GOLD COMPOUNDS USED IN THE TREATMENT OF ARTHRITIS. I. HUMAN PLASMA AND SYNOVIAL FLUID CONCENTRATION AND URINARY EXCRETION OF GOLD DURING AND FOLLOWING TREATMENT WITH GOLD SODIUM THIOMALATE, GOLD SODIUM THIOSULFATE, AND COLLOIDAL GOLD SULFIDE. J Clin Invest. 1941 Jul;20(4):401–412. doi: 10.1172/JCI101235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gerber R. C., Paulus H. E., Bluestone R., Pearson C. M. Clinical response and serum gold levels in chrysotherapy. Lack of correlation. Ann Rheum Dis. 1972 Jul;31(4):308–310. doi: 10.1136/ard.31.4.308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gottlieb N. L., Smith P. M., Smith E. M. Pharmacodynamics of 197Au and 195Au labeled aurothiomalate in blood. Correlation with course of rheumatoid arthritis, gold toxicity and gold excretion. Arthritis Rheum. 1974 Mar-Apr;17(2):171–183. doi: 10.1002/art.1780170211. [DOI] [PubMed] [Google Scholar]
  6. Jessop J. D., Johns R. G. Serum gold determinations in patients with rheumatoid arthritis receiving sodium aurothiomalate. Ann Rheum Dis. 1973 May;32(3):228–232. doi: 10.1136/ard.32.3.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kamel H., Brown D. H., Ottaway J. M., Smith W. E. Determination of gold in blood fractions by atomic-absorption spectrometry using carbon rod and carbon furnace atomisation. Analyst. 1976 Oct;101(1207):790–797. doi: 10.1039/an9760100790. [DOI] [PubMed] [Google Scholar]
  8. Krusius F. E., Markkanen A., Peltola P. Plasma levels and urinary excretion of gold during routine treatment of rheumatoid arthritis. Ann Rheum Dis. 1970 May;29(3):232–235. doi: 10.1136/ard.29.3.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. LAWRENCE J. S. Studies with radioactive gold. Ann Rheum Dis. 1961 Dec;20:341–352. doi: 10.1136/ard.20.4.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lorber A., Atkins C. J., Chang C. C., Lee Y. B., Starrs J., Bovy R. A. Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis. Ann Rheum Dis. 1973 Mar;32(2):133–139. doi: 10.1136/ard.32.2.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lorber A., Simon T. M., Leeb J., Carroll P. E., Jr Chrysotherapy: pharmacological and clinical correlates. J Rheumatol. 1975 Dec;2(4):401–410. [PubMed] [Google Scholar]
  12. Mascarenhas B. R., Granda J. L., Freyberg R. H. Gold metabolism in patients with rheumatoid arthritis treated with gold compounds--reinvestigated. Arthritis Rheum. 1972 Jul-Aug;15(4):391–402. doi: 10.1002/art.1780150410. [DOI] [PubMed] [Google Scholar]
  13. Pedersen S. M., Graabaek P. M. A unified method for the determination of gold in biological fluids by flameless atomic absorption spectroscopy. Scand J Clin Lab Invest. 1977 Feb;37(1):91–94. [PubMed] [Google Scholar]
  14. Rubinstein H. M., Dietz A. A. Serum gold. II. Levels in rheumatoid arthritis. Ann Rheum Dis. 1973 Mar;32(2):128–132. doi: 10.1136/ard.32.2.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Smith P. M., Smith E. M., Gottlieb N. L. Gold distribution in whole blood during chrysotherapy. J Lab Clin Med. 1973 Dec;82(6):930–937. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES